Trial Profile
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 18 Jun 2012 Actual end date (1 Jul 2007) added as reported by ClinicalTrials.gov.
- 04 Sep 2006 Status change
- 01 Sep 2005 New trial record.